These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20022539)
21. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. Moore RA; Derry S; Phillips CJ; McQuay HJ BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784 [TBL] [Abstract][Full Text] [Related]
22. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy]. Lanas A Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979 [TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal Antiinflammatory Drugs, Anticoagulation, and Upper Gastrointestinal Bleeding. Lee MW; Katz PO Clin Geriatr Med; 2021 Feb; 37(1):31-42. PubMed ID: 33213773 [TBL] [Abstract][Full Text] [Related]
24. Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents. You JH; Lee KK; Chan TY; Lau WH; Chan FK Aliment Pharmacol Ther; 2002 Dec; 16(12):2089-96. PubMed ID: 12452942 [TBL] [Abstract][Full Text] [Related]
25. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. Naesdal J; Wilson I Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186 [TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Peng S; Duggan A Expert Opin Drug Saf; 2005 Mar; 4(2):157-69. PubMed ID: 15794710 [TBL] [Abstract][Full Text] [Related]
32. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events. Scheiman JM; Hindley CE Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236 [TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813 [TBL] [Abstract][Full Text] [Related]
34. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Scheiman JM; Fendrick AM Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078 [TBL] [Abstract][Full Text] [Related]
35. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections? McCarthy DM Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207 [TBL] [Abstract][Full Text] [Related]
36. Is no NSAID a good NSAID? Approaches to NSAID-associated upper gastrointestinal disease. Chang SY; Howden CW Curr Gastroenterol Rep; 2004 Dec; 6(6):447-53. PubMed ID: 15527674 [TBL] [Abstract][Full Text] [Related]